Asset Management One Limited buys 3,339 shares of Balchem (NASDAQ:BCPC)
→ Know your earning potential before you trade! (from Tradewins)
A number of other hedge funds have also added to or cut stocks. Crossmark Global Holdings Inc grew its holdings in Balchem by 2.3% during the third quarter. Crossmark Global Holdings Inc. Now 3,239 shares of the staples company’s stock, valued at $393,000, after buying an additional 74 shares last quarter. Franklin Resources Inc. Its ownership in Balchem shares increased by 4.6% during the second quarter. Franklin Resources Inc. Now 2,125 shares of the staples company worth $276,000 after purchasing an additional 93 shares last quarter. The Maryland Retirement and Pension System grew its holdings in Belchem shares by 0.9% during the third quarter. Maryland Retirement and Pensions now owns 13,135 shares of the basic materials company’s stock valued at $1,597,000 after purchasing an additional 121 shares last quarter. Cardinal Capital Management increased its stake in Balchem by 0.7% during the second quarter. Cardinal Capital Management now owns 18,485 shares of the staples company valued at $2,398,000 after purchasing an additional 127 shares last quarter. Finally, Great West Life Assurance Co was able to increase its stake in shares of Balchem by 0.5% during the first quarter. Great West Life Assurance Co. can now own 28,110 shares of the basic materials company’s stock worth $3,943,000 after purchasing an additional 132 shares last quarter. Hedge funds and other institutional investors own 89.29% of the company’s shares.
Wall Street analyst forecasts for growth
Several research analysts have recently commented on BCPC stock. HC Wainwright lowered its price target on Balchem from $164.00 to $152.00 and assigned a “buy” rating to the company in a report on Monday, November 7th. StockNews.com began covering Balchem in a report on Wednesday, October 12th. They put a “hold” rating on the company.
Balshim shares increased by 3.9%.
BCPC shares opened at $135.72 on Thursday. The company has a market capitalization of $4.36 billion, a price-earnings ratio of 40.51 and a beta of 0.67. The stock has a 50-day simple moving average of $128.25 and a 200-day simple moving average of $130.56. The company has a debt-to-equity ratio of 0.54, a trading ratio of 2.59 and a quick ratio of 1.61. Balchem has a one-year low of $110.15 and a one-year high of $147.80.
Balchem (NASDAQ:BCPC — Get Rating) last released its earnings results on Friday, November 4th. The basic materials company reported earnings of $0.78 per share (EPS) for the quarter, beating the consensus estimate of $0.91 (0.13 USD). The company generated revenue of $244.27 million for the quarter, compared to analyst expectations of $241.00 million. Belchem’s return on equity was 12.28% with a net margin of 11.80%. On average, analysts expect Balchem Co to report 3.49 earnings per share for the current fiscal year.
Belchem increases dividends
The company also recently declared an annual dividend, which was paid on Friday, January 20th. Shareholders of record on Tuesday, December 27th received a dividend of $0.71. The ex-dividend date was Friday, December 23rd. This represents a yield of 0.53%. This is a positive change from Balchem’s previous annual dividend of $0.64. Belchem’s dividend payout ratio is currently 21.19%.
About Balshim Company
(Get Rating)
Balchem Corp. offers to market specialized performance components and products. It operates through the following divisions: Nutrition and Human Health, Animal Nutrition and Health, Specialty Products and Industrial Products. The Human Nutrition and Health division supplies ingredients to the food and beverage industry, providing custom solutions in solid and liquid powder and flavor delivery systems, spray-dried emulsified powder systems, and grain systems.
See also
Want to know what other hedge funds own BCPC? Visit HoldingsChannel.com for the latest 13 Balchem Co. internal filings and trades. (NASDAQ: BCPC – Get Rating).
This instant news alert was created by MarketBeat’s narrative science and financial data technology to provide readers with the fastest, most accurate reporting possible. This story was reviewed by the MarketBeat editorial team prior to publication. Please send any questions or comments about this story to [email protected]
Before you even think about balshim, you’ll want to hear this.
MarketBeat tracks Wall Street’s top-rated and top-performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat identified the five stocks top analysts are quietly whispering to their clients to buy now before the broader market catches on…and Balchem wasn’t even on the list.
While Balchem currently has a “buy” rating among analysts, the higher-rated analysts believe these five stocks are better buys.
View the five stocks here
The next step for Elon Musk
Wondering when you’ll finally be able to invest in SpaceX, StarLink, or The Boring Company? Click the link below to find out when Elon Musk will finally allow these companies to go public.
Get this free report
